Stengone Carmine N., CEO & President, Director at Contineum Therapeutics, Inc. Class A, holds 17.22K shares in Contineum Therapeutics, Inc. Class A (Ticker: CTNM), holds 1.25K shares in Kiora Pharmaceuticals (Ticker: KPRX).
What is the percentage of profitable transactions made by Stengone Carmine N.?
The percentage of profitable transactions made by Stengone Carmine N. is ―.
What is the average return per transaction made by Stengone Carmine N.?
The average return per transaction made by Stengone Carmine N. is ―.
What stocks does Stengone Carmine N. hold?
Stengone Carmine N. holds: CTNM, KPRX stocks.
What was Stengone Carmine N.’s latest transaction?
Stengone Carmine N. latest transaction was an Uninformative Buy of $2.52K.
What was Stengone Carmine N.'s most profitable transaction?
Stengone Carmine N.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Stengone Carmine N.'s role in Contineum Therapeutics, Inc. Class A?
Stengone Carmine N.'s role in Contineum Therapeutics, Inc. Class A is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.